SCHEMBL17909407

SCHEMBL17909407

CCCCOCCOCCOCCOCCCC(=O)OCCCCCCCC(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGKA P23743 1/20 0.50
▸ NAAA Q02083 1/20 0.46
▸ HTR2C P28335 1/20 0.45
▸ PRSS1 P07477 1/20 0.44
▸ PRSS2 P07478 1/20 0.44
▸ PRSS3 P35030 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ DNM1 Q05193 1/20 0.43
▸ PLA2G2A P14555 2/20 0.41
▸ NOD1 Q9Y239 1/20 0.41
▸ RAD52 P43351 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ LMNA P02545 3/20 0.40
▸ FAAH O00519 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17909035 1.00 DGKA (0.50) DGKANAAAHTR2CPRSS1PRSS2
SCHEMBL17908687 1.00 DGKA (0.50) DGKANAAAHTR2CPRSS1PRSS2
SCHEMBL17908579 1.00 DGKA (0.50) DGKANAAAHTR2CPRSS1PRSS2
SCHEMBL17909101 1.00 DGKA (0.50) DGKANAAAHTR2CPRSS1PRSS2
SCHEMBL17909214 1.00 DGKA (0.50) DGKANAAAHTR2CPRSS1PRSS2
SCHEMBL17908649 0.97 DGKA (0.54) DGKANAAAHTR2CPRSS1PRSS2
SCHEMBL17909240 0.97 DGKA (0.54) DGKANAAAHTR2CPRSS1PRSS2
SCHEMBL17909211 0.97 DGKA (0.54) DGKANAAAHTR2CPRSS1PRSS2
SCHEMBL17908724 0.97 DGKA (0.54) DGKANAAAHTR2CPRSS1PRSS2
SCHEMBL17909377 0.97 DGKA (0.54) DGKANAAAHTR2CPRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3048093-B1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF MORESCO CORP (JP) 2019-02-20 — — EP disclosed
US-10077229-B2 Ether-containing monoester compound and use thereof MORESCO CORPORATION (JP) 2018-09-18 — — US disclosed
EP-3048093-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF Moresco Corporation (JP) 2016-07-27 — — EP disclosed
US-20160200998-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF MORESCO CORPORATION (JP) 2016-07-14 — — US disclosed
CN-105579431-A Ether-containing monoester compound and use thereof MORESCO CORP 2016-05-11 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10077229-B2 Ether-containing monoester compound and use thereof SFN, CCNE2, HSD3B2 DGKA 1202/4885NAAA 4428/4885HTR2C 875/4885
US-20160200998-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF SFN, CCNE2, MSMO1 DGKA 1333/4885NAAA 4362/4885HTR2C 944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback